MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

Search

Imunon Inc

Fechado

0.67 -6.94

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.67

Máximo

0.72

Indicadores-chave

By Trading Economics

Funcionários

25

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+1817.81% upside

Dividendos

By Dow Jones

Próximos Ganhos

13 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.4M

12M

Abertura anterior

7.61

Fecho anterior

0.67

Imunon Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de jul. de 2025, 15:46 UTC

Grandes Movimentos do Mercado

BitMine Shares Fall After Closing of $250 Million Private Placement

9 de jul. de 2025, 23:44 UTC

Conversa de Mercado

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9 de jul. de 2025, 23:42 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 de jul. de 2025, 23:42 UTC

Conversa de Mercado

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9 de jul. de 2025, 22:59 UTC

Conversa de Mercado

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9 de jul. de 2025, 22:59 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

9 de jul. de 2025, 20:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

9 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de jul. de 2025, 20:26 UTC

Ganhos

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9 de jul. de 2025, 19:18 UTC

Conversa de Mercado

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9 de jul. de 2025, 19:03 UTC

Conversa de Mercado

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9 de jul. de 2025, 18:31 UTC

Conversa de Mercado

Some Fed Officials Supported Considering July Cut -- Market Talk

9 de jul. de 2025, 17:07 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk -2-

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

9 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de jul. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

9 de jul. de 2025, 16:14 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 de jul. de 2025, 16:14 UTC

Conversa de Mercado

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9 de jul. de 2025, 16:14 UTC

Aquisições, Fusões, Aquisições de Empresas

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9 de jul. de 2025, 16:12 UTC

Conversa de Mercado

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9 de jul. de 2025, 16:08 UTC

Conversa de Mercado

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9 de jul. de 2025, 15:31 UTC

Grandes Movimentos do Mercado

BitMine Shares Fall After Closing of $250M Private Placement

9 de jul. de 2025, 15:31 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9 de jul. de 2025, 15:27 UTC

Conversa de Mercado

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9 de jul. de 2025, 14:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9 de jul. de 2025, 14:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9 de jul. de 2025, 14:26 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

9 de jul. de 2025, 14:26 UTC

Conversa de Mercado

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Comparação entre Pares

Variação de preço

Imunon Inc Previsão

Preço-alvo

By TipRanks

1817.81% parte superior

Previsão para 12 meses

Média 14 USD  1817.81%

Máximo 14 USD

Mínimo 14 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Imunon Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

1

Comprar

1

Manter

0

Vender

Informação Financeira

$

Sobre Imunon Inc

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.